Stock data
泰宗 (4169)
泰宗 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$62.38M, down 2.1% from a year earlier. EPS over the last four quarters totals -NT$0.50.
Company profile
Data as of 2026-10-18
- Market
- TWSE-listed
- Industry
- Biotech & Medical Care
- Listed
- 2026-04-08
- Founded
- 1998-02-20
- Paid-in capital
- NT$664.32M
- Common shares issued
- 66,431,612
- Legal name
- 泰宗生物科技股份有限公司
- Website
- http://www.tcmbio.com/
Monthly revenue
Data as of 2026-10-17
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$62.38M | +0.3% | -2.1% |
| 2026-08 | NT$62.18M | +0.7% | +21.8% |
Year to date: +5.8% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | -0.10 |
| 2026 Q1 | -0.45 |
| 2025 Q4 | -0.08 |
| 2025 Q3 | 0.13 |
Last four quarters: -NT$0.50
Dividends
Data as of 2026-10-18
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.36 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 1,445 | 0.4% |
| 1,000–5,000 shares | 2,067 | 6.2% |
| 5,001–10,000 shares | 309 | 3.5% |
| 10,001–15,000 shares | 146 | 2.8% |
| 15,001–20,000 shares | 70 | 1.9% |
| 20,001–30,000 shares | 94 | 3.5% |
| 30,001–40,000 shares | 44 | 2.3% |
| 40,001–50,000 shares | 32 | 2.2% |
| 50,001–100,000 shares | 49 | 5.2% |
| 100,001–200,000 shares | 36 | 7.1% |
| 200,001–400,000 shares | 25 | 9.8% |
| 400,001–600,000 shares | 7 | 5.1% |
| 600,001–800,000 shares | 2 | 2.3% |
| 800,001–1,000,000 shares | 0 | 0.0% |
| 1,000,001+ shares | 14 | 47.7% |
TDCC data for 2026-10-16: 14 holders own more than 1,000 lots (47.7% of shares), and 1,445 hold less than one lot (0.4%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -39 | 0 | 0 | -39 |
| 2026-10-16 | 10 | 0 | 0 | 10 |
| 2026-10-15 | 27 | 0 | 0 | 27 |
| 2026-10-14 | 3 | 0 | 0 | 3 |
| 2026-10-13 | -30 | 0 | 0 | -30 |
| 2026-10-12 | -6 | 0 | 0 | -6 |
| 2026-10-08 | -11 | 0 | 0 | -11 |
| 2026-10-07 | 44 | 0 | 0 | 44 |
| 2026-10-06 | 20 | 0 | 0 | 20 |
| 2026-10-05 | 7 | 0 | 0 | 7 |
| 2026-10-02 | -2 | 0 | 0 | -2 |
| 2026-10-01 | -3 | 0 | 0 | -3 |
| 2026-09-30 | 37 | 0 | 0 | 37 |
| 2026-09-29 | -1 | 0 | 0 | -1 |
| 2026-09-24 | -4 | 0 | 0 | -4 |
| 2026-09-23 | -6 | 0 | 0 | -6 |
| 2026-09-22 | -1 | 0 | 0 | -1 |
| 2026-09-21 | -23 | 0 | 1 | -22 |
| 2026-09-18 | 49 | 0 | 1 | 50 |
| 2026-09-17 | -41 | 0 | 0 | -41 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 32 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$143.00 (2026-10-19).
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.